Log In
BCIQ
Print this Print this
 

C-122

  Manage Alerts
Collapse Summary General Information
Company AstraZeneca plc
DescriptionSerotonin inhibitor
Molecular Target Serotonin (5-HT) receptor
Mechanism of ActionSerotonin (5-HT) receptor antagonist
Therapeutic Modality 
Latest Stage of DevelopmentPhase I
Standard IndicationHypertension
Indication DetailsTreat pulmonary arterial hypertension (PAH)
Regulatory Designation
Partner

 Product Details
 Archive Items are loading loading
Collapse Summary Deals Information
 Deals Details
Get a free BioCentury trial today